✦ LIBER ✦

A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trial

✍ Scribed by Jian Hou, Xin Du, Jie Jin, Zhen Cai, Fangping Chen…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pomalidomide plus low-dose dexamethasone

✍ Miguel, Jesus San; Weisel, Katja; Moreau, Philippe; Lacy, Martha; Song, Kevin; D 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 374 KB

Long-term follow-up on overall survival

✍ Dimopoulos, M A; Chen, C; Spencer, A; Niesvizky, R; Attal, M; Stadtmauer, E A; P 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB

An Open-Label Single-Arm Pilot Phase II

✍ Jagannath, Sundar; Vij, Ravi; Stewart, A. Keith; Trudel, Suzanne; Jakubowiak, An 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 400 KB